Investigating the results of adding growth hormone to the ovulation stimulation regimen in microinjection and In Vitro Fertilization in patients with low ovarian reserve
Phase 3
Not yet recruiting
- Conditions
- Infertility.Female infertility associated with anovulationN97.0
- Registration Number
- IRCT20130603013566N13
- Lead Sponsor
- Vice chancellor for Research,Tabriz University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 96
Inclusion Criteria
Age less than or equal to 42 years
Absence of internal uterine anomalies such as adenomyosis and uterine fibroids and uterine abnormalities and adenomyosis
No systemic diseases
Consent to study
BMI below 30 kg/m2
The number of antral follicles below 5 on the 3rd to 5th days of the menstrual cycle per ovary
AMH less than or equal to 1 ng/ml
Exclusion Criteria
The recipient of the donor eggs
Use of surrogacy
Severe impairment of sperm parameters
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie growth hormone's impact on ovarian reserve in IVF-ICSI cycles?
How does growth hormone supplementation compare to standard ovulation stimulation protocols in patients with diminished ovarian reserve?
Which biomarkers are associated with response to growth hormone in low ovarian reserve patients undergoing IVF-ICSI?
What are the potential adverse events of growth hormone addition in IVF-ICSI for anovulation-related infertility?
Are there combination therapies involving growth hormone and other interventions for improving IVF outcomes in low ovarian reserve patients?